NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/01/2022
Back to search
Official data from USPTO
DIZAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
11/01/2022
Trademark type
Combined
Nice classes
5, 35
Filing date
09/29/2020
Registration date
11/01/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/01/2022
Last transaction
11/01/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/27/2017
First use in commerce
11/18/2019
Drawing code
3
Owner type
03
Owner location
Wuxi City, Jiangsu, CN
Examiner
NEHMER, JASON ROBERT
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "DIZAL" above four Chinese Characters. To the left of the wording is a design of two curved bands.
Holders and representatives
Holders
Dizal (Jiangsu) Pharmaceutical Co., Ltd
Representatives
Catherine M.C. Farrelly Frankfurt Kurnit Klein & Selz PC
Technical classification
Nice Classes
Class 5Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Preparations for destroying noxious animals; antiseptics; bacterial culture mediums; bouillons for bacteriological cultures; media for bacteriological cultures; bacterial poisons; balsamic preparations for medical purposes; insecticides; medicinal preparations for the mouth to be applied in the form of capsules; pharmaceutical preparations for treatment of human illnessesanti-tumor treatment; chemico-pharmaceutical preparations for treatment of human illnessesanti-tumor treatment; collyrium; medicines for alleviating constipation; solutions for contact lenses; radiological contrast substances for medical purposes; depuratives for the body; digestives for pharmaceutical purposes; analgesics; drugs for medical purposes for treatment of human illnessesanti-tumor treatment; filled portable medicine casescomprised of pharmaceuticals for treatment of human illnessesanti-tumor treatment; pharmaceutical preparationselixirs for anti-tumor treatment; mineralbath and sodium salts for medical purposes; esters for pharmaceutical purposes; ethers for pharmaceutical purposes; fungicides; gelatine for medical purposesgelatin capsules sold empty; germicides; chewing gum for medical purposes; medicated lozenges for pharmaceutical purposes; cough pastilles for pharmaceutical purposes; rat poison; antibioticsunburn and anti-inflammatory ointments for pharmaceutical purposes; organotherapy preparations; opotherapy preparations; pharmaceutical preparations for skin care; herbal teas for medicinal purposes; cachets in the nature of capsules for medicinal preparations for the mouth for pharmaceutical purposes; first-aid boxesfilled; blood plasma; radioactive substances for medical purposes; tonics being pharmaceutical preparations for the treatment of human illnessesanti-tumor treatment; blood for medical purposes; sterilizing preparations; styptic preparations; aluminum acetates for pharmaceutical purposes; acids for pharmaceutical purposes; dietetic foods adapted for medical purposes; biological preparations for medical purposes for treatment of human illnesses; dietetic beverages adapted for medical purposes; crystallized rock sugar for medical purposes; candy for medical purposes; cellulose esters for pharmaceutical purposes; cellulose ethers for pharmaceutical purposes; by-products of the processing of cereals for dietetic or medical purposes; chemical preparations for pharmaceutical purposes for the treatment of human illnessesanti-tumor treatment; medicines for dental purposes; anti-allergic and pain reduction medicines for treatment of illnesses for human purposes; diagnostic preparations for medical purposes; medicinal drinks; petroleum jelly for medical purposes; isotopes for medical purposes; dietetic substances of low sugar and salt adapted for medical use; chemical preparations as medicines for medical purposesfor anti-tumor treatment; chemical reagents for medical purposes for the treatment of human illnesses; contact lens cleaning preparations; enzymes for medical purposes; enzyme preparations for medical purposes; amino acids for medical purposes; antibiotics; bronchodilating preparations; medicinal hair growth preparations; adjuvants for medical purposes; stem cells for medical purposes; biological tissue cultures for medical purposes; medicated eye-washes; antioxidant pills for medical use; protein dietary supplements; reagent paper for medical purposes; pesticides; diagnostic biomarker reagents for medical purposes; phytotherapy preparations for medical purposes; pre-filled syringes of medicines for medical treatment purposesanti-tumor treatment; reagent paper for veterinary purposes; astringents for medical purposes; insecticidal veterinary washes; capsules made of dendrimer-based polymers for medicinal preparations for the mouthfor pharmaceuticals purposes; raw material drugspharmaceuticals for anti-tumor treatment; Chinese medicine nostrum for the treatment of tumors in humans; pharmaceutical blood preparationsa blood clotting aid and delivery system for use in human medicine; rubbing alcohol; agricultural fungicide; eye drops; insect killing preparations in the nature of pesticides; pharmaceutical preparation for application to the eye or intraocular surgery for the purpose of anti-tumor treatment; ophthalmic pharmaceutical products for anti-tumor treatment; ophthalmic preparations; candy for pharmaceutical purpose for treatment of the cough; bacteriological research preparationpreparations of reports for anti-tumor treatment for medical purposes; bacterial preparations for medical purposes for researching of human illnesses; medical probiotic supplements; medical diagnosis reagent; vaccine preparations; contact lenses care solution; contact lens disinfectant; biological agents for the treatment of cancer
Class 35
Publicity consultation and agency services in the field of medicines; provision of goods sales informationsales information about goods for anti-tumor treatment; retail store services featuring pharmaceuticalsanitary preparations and medical supplies; wholesale distributorships featuring pharmaceutical preparationssanitary preparationsmedical supplies; retail store services and wholesale store services featuring pharmaceutical drugs; retail store services and wholesale store services featuring medicinal preparations; retail store services and wholesale store services featuring sanitary preparations; retail store services and wholesale store services featuring medical supplies
Publications
History of USPTO decisions and trademark events.
47 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/01/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/30/2022
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
09/28/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
09/23/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/20/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/18/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/16/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/14/2022
IUAF
USE AMENDMENT FILED
08/31/2022
EISU
TEAS STATEMENT OF USE RECEIVED
08/31/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/01/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/04/2022
PUBO
PUBLISHED FOR OPPOSITION
01/04/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/15/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/24/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/22/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/22/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/22/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/14/2021
GNRT
NON-FINAL ACTION E-MAILED
10/14/2021
CNRT
NON-FINAL ACTION WRITTEN
10/14/2021
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
10/12/2021
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
10/05/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/16/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/11/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/10/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/10/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/03/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/03/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
09/03/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/03/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/03/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/03/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/12/2021
GNFR
FINAL REFUSAL E-MAILED
03/12/2021
CNFR
FINAL REFUSAL WRITTEN
03/12/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/03/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/02/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/02/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/01/2021
GNRT
NON-FINAL ACTION E-MAILED
03/01/2021
CNRT
NON-FINAL ACTION WRITTEN
03/01/2021
DOCK
ASSIGNED TO EXAMINER
02/22/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/13/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/12/2020
NWAP
NEW APPLICATION ENTERED
10/02/2020
Continuous trademark protection
Get notified about every new filing that threatens DIZAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.